Azitra's top three insider shareholders as of March 23, 2026 are Healthcare Llc Bayer (TenPercentOwner, 1.31Mn shares), Aaron G.L. Fletcher (TenPercentOwner, 436.17K shares), Leslie W. Kreis (TenPercentOwner, 436.17K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Healthcare Llc Bayer | 1,307,401 | 0 | 21 Jul, 2023 | |
| Leslie W. Kreis | 0 | 436,173 | 23 Jun, 2023 | |
| Aaron G.L. Fletcher | 0 | 436,173 | 23 Jun, 2023 | |
| Francisco D. Salva | President And Ceo | 338,300 | 0 | 15 Feb, 2024 |
| Travis Whitfill | Chief Operating Officer | 334,500 | 0 | 15 Feb, 2024 |
| Andrew Mcclary | 0 | 291,911 | 29 Jun, 2023 | |
| Norm Staskey | Chief Financial Officer | 51,100 | 0 | 01 Apr, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Mar, 2026 | Francisco D. Salva | Series A Convertible Non-Redeemable Preferred Stock | A | 500 | - | 500 | D | P |
| 18 Mar, 2026 | Francisco D. Salva | Series B Warrants | A | 4,064,050 | - | 4,064,050 | D | P |
| 18 Mar, 2026 | Francisco D. Salva | Series C Warrants | A | 4,064,050 | - | 4,064,050 | D | P |
| 19 Dec, 2025 | John R. Schroer | Stock Options (Right To Buy) | A | 3,003 | $0.00 | 3,003 | D | A |
| 19 Dec, 2025 | Francisco D. Salva | Stock Options (Right To Buy) | A | 59,309 | $0.00 | 59,309 | D | A |
| 19 Dec, 2025 | Norm Staskey | Stock Options (Right To Buy) | A | 15,015 | $0.00 | 15,015 | D | A |
| 19 Dec, 2025 | Travis Whitfill | Stock Options (Right To Buy) | A | 23,724 | $0.00 | 23,724 | D | A |
| 19 Dec, 2025 | Barbara Ryan | Stock Options (Right To Buy) | A | 3,003 | $0.00 | 3,003 | D | A |
| 29 Mar, 2024 | Norm Staskey | Common Stock | A | 47,600 | $0.21 | 51,100 | D | P |
| 13 Feb, 2024 | Francisco D. Salva | Common Stock | A | 333,300 | $0.30 | 338,300 | D | P |
| 13 Feb, 2024 | Travis Whitfill | Common Stock | A | 15,000 | $0.30 | 334,500 | D | P |
| 13 Feb, 2024 | Norm Staskey | Common Stock | A | 3,300 | $0.30 | 3,500 | D | P |
| 08 Sep, 2023 | Travis Whitfill | Stock Options (Right To Buy) | A | 10,000 | $0.00 | 103,152 | D | A |
| 08 Sep, 2023 | Norm Staskey | Stock Options (Right To Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Sep, 2023 | Barbara Ryan | Stock Options (Right To Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Sep, 2023 | John R. Schroer | Stock Options (Right To Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 21 Jun, 2023 | Healthcare Llc Bayer | Common Stock | A | 1,307,401 | - | 1,307,401 | D | C |
| 21 Jun, 2023 | Healthcare Llc Bayer | Series B Convertible Preferred Stock | D | 1,307,401 | $0.00 | 0 | D | C |
| 21 Jun, 2023 | Andrew Mcclary | Common stock, $0.0001 par value | A | 249,474 | - | 249,474 | I | C |
| 21 Jun, 2023 | Andrew Mcclary | Common stock, $0.0001 par value | A | 42,437 | - | 291,911 | I | C |